Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1P4 is a **pseudogene** of the UBE2V1 gene, catalogued as "UBE2V1 Pseudogene 4." Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they do not produce a functional protein. UBE2V1P4 does not encode an active enzyme or receptor and has no known biological function, disease association, or pharmacological relevance. It is not considered a therapeutic target[4]. **Key context:** - UBE2V1P4, by definition, does not produce a functional protein and is not a drug target or active biomolecule[4]. - The functional gene in this family, UBE2V1, encodes a ubiquitin-conjugating enzyme variant involved in ubiquitination and cell signaling[1][3], but the pseudogene (UBE2V1P4) does not share these functions[4]. - No evidence is available for UBE2V1P4's involvement in disease, drug interaction, biomarker applications, or safety concerns due to its lack of protein product or biological activity[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 V1 pseudogene 4 (UBE2V1P4).